Drugging the Next Undruggable KRAS Allele-Gly12Asp

被引：24
|
作者：
Zheng, Qinheng [1 ]
Peacock, D. Matthew [1 ]
Shokat, Kevan M. [1 ]
机构：
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2022年 / 65卷 / 04期
关键词：
K-RAS; BIND;
D O I：
10.1021/acs.jmedchem.2c00099
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Since its discovery as the first human oncogene in 1983, the small GTPase KRAS has been a major target of cancer drug discovery. The paper reported in this issue describes a long-awaited small molecule drug candidate of the oncogenic KRAS (G12D) mutant for the treatment of currently incurable pancreatic cancer.
引用
收藏
页码：3119 / 3122
页数：4
相关论文
共 50 条
  • [31] Immobilization of Arg-Gly-Asp (RGD) sequence in a thermosensitive hydrogel for cell delivery using pheochromocytoma cells (PC12)
    Park, KH
    Yun, K
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2004, 97 (06) : 374 - 377
  • [32] Homozygous missense variant F12 (Gly506Asp) associated with severe factor XII deficiency: a case report
    Aljabry, Mansour
    Algazlan, Aljoud
    Alsubaie, Nouf
    Bin Dher, Shatha
    Aljabri, Hassan Semar
    Alotaibi, Ghazi S.
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [33] Homozygous missense variant F12 (Gly506Asp) associated with severe factor XII deficiency: a case report
    Mansour Aljabry
    Aljoud Algazlan
    Nouf Alsubaie
    Shatha Bin Dher
    Hassan Semar Aljabri
    Ghazi S. Alotaibi
    Journal of Medical Case Reports, 17
  • [34] Diagnostic utility of KRAS G12V mutation detection in adenomatoid odontogenic tumour by next generation sequencing
    Matthews, H.
    Leslie, C.
    Cernelc, J.
    HISTOPATHOLOGY, 2024, 85 : 23 - 23
  • [35] Characterization of the novel HLA-DRB113:03:12 allele by two next-generation sequencing methods
    Loginova, Maria
    Smirnova, Daria
    Druzhinina, Svetlana
    Kashin, Konstantin
    Paramonov, Igor
    HLA, 2022, 100 (01) : 96 - 97
  • [36] Mutation Quantitation Using Error-corrected Next Generation Sequencing of Known Mutant Fractions on Kras Codon 12.
    McKinzie, P.
    Bishop, M.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 : 78 - 78
  • [37] KRASG12D INITIATES ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA IN COOPERATION WITH LOSS OF THE WILD-TYPE KRAS ALLELE
    Staffas, A.
    Karlsson, C.
    Palmqvist, L.
    Bergo, M. O.
    HAEMATOLOGICA, 2013, 98 : 3 - 3
  • [38] Selective targeting of the oncogenic KRAS G12S mutant allele by CRISPR/Cas9 induces efficient tumor regression
    Gao, Qianqian
    Ouyang, Wenjie
    Kang, Bin
    Han, Xu
    Xiong, Ying
    Ding, Renpeng
    Li, Yijian
    Wang, Fei
    Huang, Lei
    Chen, Lei
    Wang, Dan
    Dong, Xuan
    Zhang, Zhao
    Li, Yanshan
    Ze, Baichen
    Hou, Yong
    Yang, Huanming
    Ma, Yuanyuan
    Gu, Ying
    Chao, Cheng-Chi
    THERANOSTICS, 2020, 10 (11): : 5137 - 5153
  • [39] A Novel HLA Class I Allele, HLA-C*12:424, Identified Using Next-Generation Sequencing
    Glover, Jonathon
    Hagerty, Melanie
    Pimpinella, Eric
    Carozza, Carly
    Berka, Noureddine
    HLA, 2024, 104 (05)
  • [40] The novel HLA-DQA103:01:12 allele identified using next-generation sequencing in a Melanesian individual
    Raz, Maxime
    Demortier, Justine
    Frassati, Coralie
    Picard, Christophe
    Pedini, Pascal
    HLA, 2023, 102 (05) : 643 - 645
12345